Rohit Loomba Selected Research

Bile Acids and Salts (Bile Acids)

1/2023	Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants.
1/2023	Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
1/2022	Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis.
1/2021	Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
1/2021	Mechanisms and disease consequences of nonalcoholic fatty liver disease.
1/2021	Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD.
1/2019	Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
1/2018	Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.
1/2018	Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
3/2015	Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rohit Loomba Research Topics

Disease

161	Non-alcoholic Fatty Liver Disease 04/2024 - 08/2007
142	Fibrosis (Cirrhosis) 05/2024 - 04/2009
50	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 05/2013
44	Liver Diseases (Liver Disease) 04/2024 - 10/2009
24	Inflammation (Inflammations) 03/2024 - 02/2014
23	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 01/2014
23	Alcoholic Fatty Liver 11/2023 - 03/2015
22	Fatty Liver 03/2024 - 10/2009
14	Obesity 05/2024 - 04/2008
13	Insulin Resistance 01/2021 - 08/2007
11	Hypertension (High Blood Pressure) 05/2024 - 09/2010
9	Type 2 Diabetes Mellitus (MODY) 01/2023 - 09/2014
9	Infections 01/2021 - 04/2009
8	Neoplasms (Cancer) 12/2022 - 04/2008
8	Chronic Hepatitis B 01/2022 - 01/2006
7	Hepatitis B 01/2023 - 01/2006
7	Pruritus (Itching) 01/2023 - 03/2015
7	Weight Loss (Weight Reduction) 01/2022 - 10/2009
6	Body Weight (Weight, Body) 11/2023 - 08/2007
6	COVID-19 11/2023 - 01/2020
5	Diabetes Mellitus 04/2024 - 01/2013
5	End Stage Liver Disease 04/2024 - 01/2018
5	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 01/2015
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 09/2010
4	Portal Hypertension 03/2024 - 10/2017
4	Nausea 01/2024 - 12/2019
3	Hepatitis 03/2024 - 04/2008
3	Alcoholic Hepatitis 03/2024 - 07/2015
3	Alcoholism (Alcohol Abuse) 03/2024 - 01/2015
3	Diarrhea 01/2024 - 10/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2012
3	Dyslipidemias (Dyslipidemia) 01/2023 - 09/2010
3	Liver Neoplasms (Liver Cancer) 01/2022 - 10/2020
3	Weight Gain 10/2021 - 08/2007
3	Liver Failure 01/2018 - 04/2008
3	Hemorrhage 10/2017 - 01/2013
3	Carcinogenesis 12/2016 - 05/2013
2	Varicose Veins (Varicose Vein) 05/2024 - 04/2021
2	Hypertriglyceridemia 09/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2010
49	Protons (Proton)IBA 04/2024 - 01/2013
24	Alanine Transaminase (SGPT)IBA 02/2024 - 08/2007
21	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 04/2008
17	nasIBA 03/2024 - 09/2016
13	Triglycerides (Triacylglycerol)IBA 05/2024 - 09/2010
13	obeticholic acidIBA 11/2023 - 03/2015
11	Insulin (Novolin)FDA Link 01/2023 - 10/2009
10	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 08/2015
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2009
10	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 03/2015
10	CollagenIBA 06/2022 - 01/2017
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 10/2017
7	LipidsIBA 11/2023 - 02/2014
7	selonsertibIBA 01/2023 - 01/2018
7	Antiviral Agents (Antivirals)IBA 12/2022 - 10/2009
6	firsocostatIBA 01/2023 - 11/2018
6	EnzymesIBA 11/2021 - 10/2009
6	BilirubinIBA 01/2021 - 12/2010
6	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2015
5	Transaminases (Aminotransferases)IBA 11/2023 - 09/2016
5	PegbelferminIBA 04/2023 - 12/2019
5	Pioglitazone (Actos)FDA Link 10/2021 - 08/2007
5	CholesterolIBA 01/2021 - 03/2013
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 04/2008
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2023 - 01/2020
4	cenicrivirocIBA 10/2023 - 01/2018
4	fibroblast growth factor 21IBA 09/2023 - 01/2019
4	semaglutideIBA 08/2023 - 11/2021
4	TransferasesIBA 01/2023 - 11/2010
4	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2009
4	simtuzumabIBA 01/2023 - 01/2018
4	cilofexorIBA 01/2023 - 01/2021
4	HDL CholesterolIBA 01/2023 - 01/2012
4	Vitamin E FDA LinkGeneric 10/2021 - 05/2014
3	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2020
3	resmetiromIBA 03/2024 - 01/2024
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 01/2023
3	CalciumIBA 06/2023 - 01/2016
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2023 - 01/2018
3	clonidine-displacing substance (ClDS)IBA 01/2022 - 10/2017
3	Tenofovir (Viread)FDA Link 01/2022 - 10/2015
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2021 - 01/2021
3	Keratin-18 (Keratin 18)IBA 01/2021 - 12/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020 - 11/2010
3	LigandsIBA 12/2019 - 03/2015
3	Hemoglobins (Hemoglobin)IBA 10/2019 - 11/2016
3	LDL Lipoproteins (beta Lipoproteins)IBA 10/2019 - 09/2010
3	AlbuminsIBA 07/2015 - 12/2010
3	Interleukin-6 (Interleukin 6)IBA 10/2013 - 01/2012
2	oxidized low density lipoproteinIBA 05/2024 - 01/2020
2	Phospholipases (Phospholipase)IBA 04/2024 - 01/2019
2	Ramipril (Altace)FDA LinkGeneric 11/2023 - 01/2021
2	tropifexorIBA 10/2023 - 01/2020
2	Complement C3 (C3 Complement)IBA 04/2023 - 01/2019

Therapy/Procedure

62	Therapeutics 04/2024 - 01/2006
18	Liver Transplantation 05/2024 - 06/2008
7	Drug Therapy (Chemotherapy) 12/2021 - 04/2008
4	Aftercare (After-Treatment) 01/2022 - 06/2015
2	Chemoprevention 12/2023 - 01/2023